Satellos to Participate in Upcoming Investor Conferences
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences in September. 2026 Cantor Global Healthcare ConferenceDate: Wednesday, September 9,…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- enGene to Participate in Upcoming Investor Conferences financialpost.com
